Welcome to the Entresto on-demand webinars page. Below you can access recordings from educational webinars that were hosted by experts in the field of heart failure and were organised by Novartis.
You will be required to register to watch the videos.
Five years of experience with Entresto (sacubitril/valsartan): looking back and moving forward – virtual symposium
A recording from the Novartis symposium at the British Society for Heart Failure’s 23rd annual autumn meeting, which took place virtually.
Prominent cardiologists Dr Patricia Campbell and Professor Mark Petrie exchange their experiences on using Entresto in the field of chronic heart failure.
Early initiation of Entresto® (sacubitril/valsartan): alter the cycle of readmission in patients with heart failure
Watch Dr Aaron Wong and Professor Jawad Khan present how early initiation of Entresto can alter the cycle of readmission in chronic HFrEF patients, looking at local data supporting this.
Indication: Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1
HFrEF, heart failure with reduced ejection fraction.
- Entresto Summary of Product Characteristics, 2020.